StockData
Calidi Biotherapeutics, Inc. logo

Calidi Biotherapeutics, Inc. (CLDI) stock

CLDINYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CLDWW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 3/30
$0.56−0.04 (-7.07%)

Close on Nov 17, 2026Market cap $1.45MP/E –Yield –

Calidi Biotherapeutics EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Calidi Biotherapeutics's EPS for the twelve months ending Sep 30, 2023 was -$27.07. For fiscal 2025 it was -$5.95.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$5.95–
FY2024Dec 31, 2024-$35.70–
FY2023Dec 31, 2023-$17.33-158.0%
FY2022Dec 31, 2022$29.90–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.94–
Q1 FY2026Mar 31, 2026-$0.43–
Q3 FY2025Sep 30, 2025-$2.21–
Q2 FY2025Jun 30, 2025-$31.75–
Q1 FY2025Mar 31, 2025-$2.21–
Q3 FY2024Sep 30, 2024-$7.75–
Q2 FY2024Jun 30, 2024-$16.75–
Q1 FY2024Mar 31, 2024-$2.03–
Q3 FY2023Sep 30, 2023-$1.41–
Q2 FY2023Jun 30, 2023-$14.24–
Q1 FY2023Mar 31, 2023-$7.50–
Q4 FY2022Dec 31, 2022-$3.92–
Q3 FY2022Sep 30, 2022-$6.30–

More Calidi Biotherapeutics figures

See a number that looks wrong?